Professor Osborn Almeida (Max Planck Institute of Psychiatry)

Lecture title: Stress and Mental Healthspan


Professor Marcel Hibert (Laboratoire d’Innovation Thérapeutique, Faculty of Pharmacy, University of Strasbourg, France)

Lecture title: In the shadow of Eros: medicinal chemistry of love and autism?


Professor Martin Schwab (Institute of Regenerative Medicine (IREM), University of Zurich and Dept. of Health Sciences and Technology, ETH Zurich)
Lecture title: Neurobiological mechanisms of functional recovery after spinal cord injury or stroke; the long way from the lab bench to the clinic with a neurite growth enhancing therapy


Professor Sabatino Maione (Department of Experimental Medicine, Division of Pharmacology, University of Campania "L. Vanvitelli", Napoli, Italy)

Lecture title: N-acylethanolamines modulate pain transmission and the associated maladaptive neuroplasticity

Dr  Eliyahu Dremencov (Institute of Molecular Physiology and Genetics, Centre for Biosciences, Slovak Academy of Sciences, Bratislava, Slovakia; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia)
Lecture title: The effect of prenatal immune challenge in rats on the maternal-care behavior and on monoamine neurotransmission in offsprings

Professor Yousef Tizabi (Department of Pharmacology, Howard University College of Medicine, Washington, USA)
Lecture title: In Search of Novel Antidepressants and/or Neuroprotectants

Professor Robert J. Lefkowitz, MD (Duke University Medical Center, USA)
Lecture title: Seven transmembrane receptors

Professor dr hab. Daniel Svozil (University of Chemical Technology, Department of Informatics and Chemistry, Prague)
Lecture title: Molecular morphing - artificial non-intelligent way for de novo molecular design

Dr Dasiel O. Borroto Escuela (Department of Neuroscience, Karolinska Institutet, Stockholm)  
Lecture title: Allosteric receptor-receptor interactions in homo-and heteroreceptor complexes give a new dimension to the understanding of substance use disorder